A story in the Minneapolis Star Tribune notes that Johnson & Johnson’s hip joints, currently the basis of an investigation by federal prosecutors, were part of a string of 30 recalls by the company over the past three-and-a-half years.
Johnson & Johnson revealed the government investigation in a recent report to the Securities and Exchange Commission.
According to the regulatory filing, the U.S. Attorney’s Office in Massachusetts and the Civil Division of ...
continue reading...
Johnson & Johnson has recalled a metal hip component sold outside the United States, called Adept modular heads, Reuters reports.
The company is already facing about 10,000 lawsuits connected to another model of all-metal hip implant called the ASR, which was recalled in 2010 over its tendency to break down early and leave toxic metal debris in patients’ bodies.
The Reuters story ...
continue reading...A story in U.K. newspaper The Telegraph says Johnson & Johnson employees were not only aware of problems with its ASR hip implant for years before the device’s 2010 recall, but actively discussed manipulating data to conceal those problems.
Studies show that nearly half of the implants, made by Johnson & Johnson subsidiary DePuy Orthopaedics, break down and need replacement after only a few years. They also have a tendency to ...
continue reading...An editorial in the New York Times takes Johnson & Johnson subsidiary DePuy Orthopaedics to task for apparently sitting on evidence that a line of its hip implants posed a danger to patients.
“Though the company says the evidence will ultimately show that it acted appropriately, it clearly has a lot of explaining to do,” the editorial says.
The model in question ...
continue reading...
During a trial centering on Johnson & Johnson’s ASR hip implants, Bloomberg reports, a biomedical engineering expert told the jury that the devices had multiple design flaws.
Johnson & Johnson recalled the all-metal implants, manufactured by subsidiary DePuy Orthopaedics, in 2010. At the time, the company said 12 percent fail within five years. Subsequent studies found that nearly half of them ...
continue reading...
A piece in The Economist deals with the negative information coming out in Johnson & Johnson’s trial over ASR hip implants manufactured by its subsidiary, DePuy Orthopaedics.
“Most companies do everything they can to keep their executives away from court,” the piece states. “A case in California helps to demonstrate why.”
Studies have shown nearly half of the implants break down and ...
continue reading...
